share_log

Apogee Therapeutics | 8-K: Apogee Therapeutics Provides Pipeline Progress and Reports Third Quarter 2024 Financial Results

SEC ·  Nov 12 22:49
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.